Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NLGase inhibitors(β-glucosidase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Niemann-Pick Disease, Type C | IND Application | CA | 14 Jun 2024 |